| 000 | 01110 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511200352.0 | ||
| 264 | 0 | _c19910703 | |
| 008 | 199107s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(91)93086-o _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, A M | |
| 245 | 0 | 0 |
_aAll-oral chemotherapy in refractory Hodgkin's disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 1991 |
||
| 300 |
_a1408 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 700 | 1 | _aMoreb, J | |
| 700 | 1 | _aKilleen, R B | |
| 773 | 0 |
_tLancet (London, England) _gvol. 337 _gno. 8754 _gp. 1408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(91)93086-o _zAvailable from publisher's website |
| 999 |
_c1681189 _d1681189 |
||